The first gene-editing treatment for Sickle Cell
“Many CRISPR treatments are in trials, but in 2022, Vertex Pharmaceuticals, based in Boston, [MORE]
It wasn’t long ago that American healthcare was touted as the best in the world. That was then; this [MORE]
Unnecessary care, administrative inefficiency, provider errors, preventable conditions, and lack of care coordination add up to a large waste bill [MORE]